Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Oramed Pharmaceuticals Inc.    ORMP

ORAMED PHARMACEUTICALS INC.

(ORMP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ORAMED PHARMACEUTICALS INC.

- No events available -

Past events on ORAMED PHARMACEUTICALS INC.
01/13/21 Q1 2021 Earnings Release (Projected)
01/11/21 H.C. Wainwright Bioconnect Conference
11/18/20 | 10:00am Investor Meeting
11/12/20 | 11:30am H.C. Wainwright Israel Conference
Upcoming sector events for ORAMED PHARMACEUTICALS INC.
01/27/21 LONZA GROUP LTD : Jahr 2020 Ergebnisveröffentlichung
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
02/02/21 BIO-TECHNE CORPORATION : Erstes Halbjahr 2021 Ergebnisveröffentlichung
02/02/21 | 03:00pm BIO-TECHNE CORPORATION : Erstes Halbjahr 2021 Präsentation des Ergebnisses
More events
Past sector events for ORAMED PHARMACEUTICALS INC.
01/21/21 | 06:00am SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Ausserordentliche Aktionärsversammlung
01/21/21 BIOCON LIMITED : Q3 2021 Ergebnisveröffentlichung
01/20/21 | 12:00pm EVOTEC SE : Unicredit & KeplerCheuvreux German Corporate Conference
01/19/21 | 10:30pm UNITED THERAPEUTICS CORPORATION : Tyvaso Study Results Call
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
0,64
0,48
34%
2,46
2,45
0,35%
2,45
2,43
0,66%
2,70
2,70
0,22%
2,71
3,96
-31%

2,77
Operating income
(EBITDA)
M $
Released
Forecast
Spread




-13,5
-15,3
11%






Operating profit
(EBIT)
M $
Released
Forecast
Spread
-10,0
-8,72
-15%
-10,8
-11,5
6,3%
-13,5
-15,2
11%
-14,6
-16,7
13%
-11,8
-16,9
30%

-19,2
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-9,63
-8,48
-14%
-10,1
-10,7
5,9%
-12,7
-14,3
11%
-14,1
-16,0
12%
-11,5
-11,9
3,5%

-18,6
Net income
M $
Released
Forecast
Spread
-11,0
-8,48
-29%
-10,5
-11,1
5,7%
-12,7
-14,3
11%
-14,4
-15,8
9,2%
-11,5
-11,9
3,5%

-18,6
EPS
$
Released
Forecast
Spread
-0,87
-0,67
-30%
-0,79
-0,83
4,8%
-0,86
-0,96
9,9%
-0,82
-0,90
8,9%
-0,56
-0,58
4,0%

-0,76
Announcement Date11/25/201611/29/201711/28/201811/27/201911/24/2020

Quarterly publications
Previous periodNext period
Quarterly results2020 Q12020 Q22020 Q32020 Q42021 Q12021 Q2 (e)
Sales
M $
Released
Forecast
Spread
0,67
0,65
3,7%
0,67
0,33
107%
0,68
0,51
35%
0,68
1,43
-52%
0,67
0,67
1,3%

0,67
Operating income
(EBITDA)
M $
Released
Forecast
Spread












Operating profit
(EBIT)
M $
Released
Forecast
Spread
-2,43
-4,25
43%
-4,04
-3,95
-2,2%
-2,27
-3,58
36%
-3,02
-5,21
42%
-5,83
-9,05
36%

-10,1
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-2,54
-4,04
37%
-3,69
-3,53
-4,6%
-2,28
-3,89
41%
-3,00
-3,36
11%
-5,57
-8,84
37%

-7,04
Net income
M $
Released
Forecast
Spread
-2,54
-4,04
37%
-3,69
-3,52
-4,9%
-2,28
-3,88
41%
-3,00
-3,36
11%
-5,57
-6,18
9,9%

-6,13
EPS
$
Released
Forecast
Spread
-0,15
-0,25
39%
-0,21
-0,18
-20%
-0,10
-0,17
40%
-0,10
-0,15
32%
-0,23
-0,19
-19%

-0,19
Announcement Date01/09/202004/06/202007/07/202011/24/202001/14/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise